Fundz

Who to call at OXB, and when

Fundz watches for the moments OXB starts buying, and tells you who to reach.

  • An alert the day OXB raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at OXB, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at OXB. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

OXB and Aura Biosciences form partnership to support Phase 3 development of oncology candidate.

Nov 17, 2026

Contract Type

partnership

ManufacturingBiotechnologyHealth CareTherapeuticsBiopharma

Description

OXB has confirmed a partnership with Aura Biosciences aimed at supporting the Phase 3 development of its lead oncology candidate. This collaboration also includes provisions for future commercial supply, enhancing OXB's capabilities in oncology treatments.

Quick answer

OXB and Aura Biosciences form partnership to support Phase 3 development of oncology candidate. (November 17, 2026).

What agreement did OXB announce on November 17, 2026?
OXB has confirmed a partnership with Aura Biosciences aimed at supporting the Phase 3 development of its lead oncology candidate. This collaboration also includes provisions for future commercial supply, enhancing OXB's capabilities in oncology treatments.
What does OXB do?
OXB is a biopharmaceutical company dedicated to advancing the development of innovative therapies.
Which similar companies announced agreements around the same time?
Sino Biopharmaceutical (November 13, 2026), AbbVie Inc. (November 3, 2026), AstraZeneca Pharma India (November 17, 2026) and Pfizer (November 14, 2026) also announced agreements within 45 days of OXB.

Source: Fundz verified event record.

Other recent agreements in Therapeutics and Biopharma

Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.

Company Information

Company

OXB

About

OXB is a biopharmaceutical company dedicated to advancing the development of innovative therapies. They focus on developing and manufacturing gene and cell therapies for a range of diseases. The company is committed to bringing new solutions to patients in need.

Predictive Intelligence
Strategic

ML-powered predictions for OXB's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

OXB signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.